Synthesis and in vitro bio-activity evaluation of N4-benzyl substituted 5-chloroisatin-3-thiosemicarbazones as urease and glycation inhibitors
DOI:
https://doi.org/10.17344/acsi.2017.3649Keywords:
5-Chloroisatin, Glycation inhibition, Heterocyclics, Schiff bases, Thiosemicarbazones, Urease inhibitionAbstract
A series of fifteen N4-benzyl substituted 5-chloroisatin-3-thiosemicarbazones 5a–o were synthesized and screened mainly for their antiurease and antiglycation effects. Lemna aequinocitalis growth and Artemia salina assays were carried out to determine their phytotoxicity and cytotoxicity potential. All the compounds proved to be extremely effective urease inhibitors, demonstrating enzyme inhibition much better than the reference inhibitor, thiourea (IC50 values 1.31 ± 0.06 to 3.24 ± 0.15 vs. 22.3 ± 1.12 μM). On the other hand, eight out of fifteen compounds tested, i.e. 5b, 5c, 5h–k, 5m and 5n were found to be potent glycation inhibitors. Of these, five viz. 5c, 5h–j and 5n proved to be exceedingly efficient, displaying glycation inhibition greater than the reference inhibitor, rutin (IC50 values 114.51 ± 1.08 to 229.94 ± 3.40 vs. 294.5 ± 1.5 μM).
Downloads
Additional Files
Published
Issue
Section
License
Except where otherwise noted, articles in this journal are published under the Creative Commons Attribution 4.0 International License